Skip to main content
. Author manuscript; available in PMC: 2023 Aug 2.
Published in final edited form as: Mol Cancer Res. 2023 Aug 1;21(8):795–807. doi: 10.1158/1541-7786.MCR-23-0002

Figure 6. Similar and distinct NE score-associated therapeutic sensitivity in SCLC and NBL cell lines.

Figure 6.

A. Correlation between NE scores and therapeutic sensitivity for drugs with selected targets. Therapeutic sensitivity data was previously harmonized such that a higher value represents more resistance in each study. For each of the nine selected targets, all compounds with the same target were identified from multiple studies. Pearson correlation coefficient r from correlating compound data with NE scores were calculated for NBL lines (x-axis values) and SCLC lines (y-axis values) respectively and visualized as a scatter plot, with colors annotating the source of data, and transparency annotating the statistical significance. B. Meta-analysis-summarized correlation between drug therapeutic sensitivity and NE scores in NBL (x-axis) and SCLC (y-axis) cell lines. Note that high NE scores are associated with resistance to inhibitors of LCK, MEK, XIAP, mTOR, HSP90, and Abl, and sensitivity to BCL inhibitors. NE scores are associated with resistance to BRD inhibitors in NBL but not SCLC whereas microtubule inhibitors resistance correlates with high NE scores in SCLC but not NBL cell lines.